Skip to content

Clinical trials

Observational Uterine Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Neoplasms Phase: Observational Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20062
20083
20092
20101
20112
20121
20131
20143
20151
20161
20174
20184
20194
20203
20214
20224
20232
20246
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting17
Unknown status9
Not yet recruiting6
Terminated3
Withdrawn2
Active, not recruiting2
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center5
Memorial Sloan Kettering Cancer Center5
Affidea Nu-med Center of Oncological DIagnostics and Therapy2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Imperial College London2
Precision Therapeutics2
University of New Mexico2
Abramson Cancer Center at Penn Medicine1
Aesculap AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Neoplasms65
Ovarian Neoplasms27
Uterine Cervical Neoplasms26
Endometrial Neoplasms21
Vulvar Neoplasms13
Vaginal Neoplasms11
Breast Neoplasms10
Lung Neoplasms10
Stomach Neoplasms10
Fallopian Tube Neoplasms9

Trials

Showing 26 to 50 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.